{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "1924",
                "1933"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Rytmonorm"
        },
        {
            "identifier": "T2",
            "position": [
                "1889",
                "1911"
            ],
            "subtype": "Investigation",
            "type": "T",
            "value": "przeprowadzenia  bada\u0144"
        },
        {
            "identifier": "T3",
            "position": [
                "1567",
                "1598"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "blokiem przedsionkowo komorowym"
        },
        {
            "identifier": "T4",
            "position": [
                "1421",
                "1431"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Propafenon"
        },
        {
            "identifier": "T5",
            "position": [
                "1183",
                "1206"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "propafenonu (Rytmonorm)"
        },
        {
            "identifier": "T6",
            "position": [
                "1207",
                "1242"
            ],
            "subtype": "Drug_dose",
            "type": "T",
            "value": "3x dziennie po 1,5 tabletki a 150mg"
        },
        {
            "identifier": "T7",
            "position": [
                "1024",
                "1033"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Rytmonorm"
        },
        {
            "identifier": "T8",
            "position": [
                "1016",
                "1022"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Concor"
        },
        {
            "identifier": "T9",
            "position": [
                "1036",
                "1041"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Asmag"
        },
        {
            "identifier": "T10",
            "position": [
                "824",
                "840"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "niedomykalno\u015bci\u0105"
        },
        {
            "identifier": "T11",
            "position": [
                "745",
                "817"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Wrodzona wada serca pod postaci\u0105 \u0142agodnej dysplazji zastawki dwudzielnej"
        },
        {
            "identifier": "T12",
            "position": [
                "846",
                "875"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Z\u0142o\u017cona arytmia przedsionkowa"
        },
        {
            "identifier": "T13",
            "position": [
                "431",
                "469"
            ],
            "subtype": "Investigation",
            "type": "T",
            "value": "Kontrolny Holter w Klinice Kardiologii"
        },
        {
            "identifier": "T14",
            "position": [
                "470",
                "487"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "w dniu 25.04.2018"
        },
        {
            "identifier": "T15",
            "position": [
                "399",
                "428"
            ],
            "subtype": "Investigation",
            "type": "T",
            "value": "kontrola ci\u015bnienia t\u0119tniczego"
        },
        {
            "identifier": "T16",
            "position": [
                "344",
                "353"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Rytmonorm"
        },
        {
            "identifier": "T17",
            "position": [
                "354",
                "389"
            ],
            "subtype": "Drug_dose",
            "type": "T",
            "value": "1,5 tabl-1 tabl- 1,5 tabl. a 150 mg"
        },
        {
            "identifier": "T18",
            "position": [
                "1247",
                "1289"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "Wizyta kontrolna w Poradni Kardiologicznej"
        },
        {
            "identifier": "T19",
            "position": [
                "1290",
                "1300"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "za miesi\u0105c"
        },
        {
            "icd": "ICD10:I44.3",
            "identifier": "N1",
            "referenced": "T3",
            "subtype": "Reference",
            "type": "N",
            "value": "Inne i nieokre\u00c5\u009blone bloki przedsionkowo-komorowe"
        },
        {
            "icd": "ICD10:I37.1",
            "identifier": "N2",
            "referenced": "T10",
            "subtype": "Reference",
            "type": "N",
            "value": "Niedomykalno\u00c5\u009b\u00c4\u0087 zastawki pnia p\u00c5\u0082ucnego"
        },
        {
            "icd": "ICD10:Q23.8",
            "identifier": "N3",
            "referenced": "T11",
            "subtype": "Reference",
            "type": "N",
            "value": "Inne wrodzone wady rozwojowe zastawki aortalnej i zastawki mitralnej"
        },
        {
            "icd": "ICD10:I49.1",
            "identifier": "N4",
            "referenced": "T12",
            "subtype": "Reference",
            "type": "N",
            "value": "Przedwczesna depolaryzacja przedsionkowa [pobudzenie przedsionkowe]"
        },
        {
            "arg1": "T16",
            "arg2": "T17",
            "identifier": "R1",
            "subtype": "Drg",
            "type": "R"
        },
        {
            "arg1": "T5",
            "arg2": "T6",
            "identifier": "R2",
            "subtype": "Drg",
            "type": "R"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 17 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: m\u0119ska\n------------------------------------------------\n------------------------------------------------\nZalecenia\n------------------------------------------------\nPrzyjmowanie:\n-Rytmonorm 1,5 tabl-1 tabl- 1,5 tabl. a 150 mg\nOkresowa kontrola ci\u015bnienia t\u0119tniczego .\nKontrolny Holter w Klinice Kardiologii w dniu 25.04.2018 ( konieczne skierowanie od lekarza POZ)\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: |Rozpoznanie II: |Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Wrodzona wada serca pod postaci\u0105 \u0142agodnej dysplazji zastawki dwudzielnej z jej niedomykalno\u015bci\u0105 .\\x0aZ\u0142o\u017cona arytmia przedsionkowa.\\x0a\\x0aQ23.3, I49.1\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nConcor. Rytmonorm , Asmag\n------------------------------------------------\nZalecenia\n------------------------------------------------\n1. Dalsze regularne przyjmowanie propafenonu (Rytmonorm) 3x dziennie po 1,5 tabletki a 150mg.\n2. Wizyta kontrolna w Poradni Kardiologicznej za miesi\u0105c.\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nPropafenon\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nCh\u0142opiec z blokiem przedsionkowo komorowym przyj\u0119ty do Kliniki do poszerzonych bada\u0144 i ustalenia dalszego post\u0119powania Stan do\u015b\u0107 dobry\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nCh\u0142opak 17  letni  w  stanie   dobrym  zosta\u0142  przyj\u0119ty do  Kliniki celem przeprowadzenia  bada\u0144 \nOtrzymuje  Rytmonorm \n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nMorfologia\n    WBC:5.62[10\\\\^3/ul]\n    RBC:5.31[10\\\\^6/ul]\n    HGB:16.1[g/dl]\n    HCT:46.9[%]\n    MCV:88.3[fl]\n    MCH:30.3[pg]\n    MCHC:34.3[g/dl]\n    PLT:221.0[10\\\\^3/ul]\n    RDW-SD:40.3[fl]\n    RDW-CV:12.5[%]\n    PDW:16.7[fl]\n    MPV:12.6[fl]\n    P-LCR:48.7[%]\n    PCT:0.3[%]\n    NEUTR#:2.34[10\\\\^3/ul]\n    NEUTR%:41.6[%]\n    LYMPH#:2.40[10\\\\^3/ul]\n    LYMPH%:42.7[%]\n    MONO#:0.69[10\\\\^3/ul]\n    MONO%:12.30[%]\n    EO#:0.18[10\\\\^3/ul]\n    EO%:3.20[%]\n    BASO#:0.01[10\\\\^3/ul]\n    BASO%:0.20[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nABL Parametry krytyczne\n    pH:7.307\n    pCO2:61.7[mmHg]\n    BE:1.90[mmol/L]\n    HCO3:29.9[mmol/L]\n    pO2:25.7[mmHg]\n    O2Sat:34.4[%]\n    Na - ABL:138[mmol/L]\n    K - ABL:4.6[mmol/L]\n    Cl - ABL:103[mmol/L]\n    Ca zj ABL:1.22[mmol/L]\n    Ht - ABL:51.7[%]\n    Hb ABL:16.9[g/dl]\n    FO2Hb:34.2[%]\n    FCOHb:0.3[%]\n    FMetHb:0.4[%]\n    FHbF - ABL:*[%]\n    GLU-ABL:113[mg/dl]\n    mleczany:16[mg/dl]\n    COMMENT_HL7:\nImmununochemia -Immulite: COMMENT_HL7:\nChemia Kliniczna: COMMENT_HL7:\nChemia Kliniczna: COMMENT_HL7:\nD-dimery t. ilo\u015bciowy: D-dimer:34.0[ng/ml]\nPLT -  z koagulogramu: PLT-KOAG:124.0[10\\\\^3/ul]\nFibrynogen (F): FIB:2.70[g/L]\nAntytrombina III (ATIII): ATIII:124.0[%]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:32.5[s]\nINR: INR:1.3\nCzas protrombinowy (PT): PT:13.8[s]\nCzas trombinowy (TT): TT:14.6[s]\nKwas mlekowy: LAC:23.80[mg/dl]\nKwas mlekowy: LAC:95.40[mg/dl]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nWska\u017anik PT: PT%:80[%]\nKreatynina: CREA:0.80[mg/dl]\nMocznik: UREA:37.00[mg/dl]\nASPAT: AST:22.00[IU/L]\nALAT: ALT:29.00[IU/L]\nNT- proBNP: NTpBNP:40.20[pg/ml]\nTSH: TSH:1.58[uIU/ml]\nPosiew - Wymaz z nosa: POSIEW:\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:67.1[ml/min/1,73m2]\nWzrost pacjenta: WzrostPac:130[cm]\neGFR (13-18r\u017c M) stand.wg.Schwartza  wsp. 0.700: eGFR13-18M:113.7[ml/min/1,73m2]\nFT3 III: FT3 III:3.11[pg/ml]\nFT4II: FT4II:1.30[ng/dl]\n------------------------------------------------\nICD10\n------------------------------------------------\nQ23.3\nI49.1\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n88.721\n89.541\n------------------------------------------------"
}